Concourse Financial Group Securities, Inc. Bio Path Holdings Inc Transaction History
Concourse Financial Group Securities, Inc.
- $1.64 Billion
- Q3 2024
Shares
21 transactions
About BIO-PATH HOLDINGS INC
- Ticker BPTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 7,160,160
- Market Cap $6.37M
- Description
- Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the...